Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00898807 · ClinicalTrials.gov registry record · Phase 3
Citalopram for Agitation in Alzheimer's Disease
A Phase 3 study, sponsored by JHSPH Center for Clinical Trials.
- Completed
- Registry status
- Phase 3
- Development phase
- 186
- Enrollment target
NCT00898807 is a Phase 3 study that has completed, run by JHSPH Center for Clinical Trials. The registered enrollment target is 186 participants.
The verdict
NCT00898807, a Phase 3 study, has completed, sponsored by JHSPH Center for Clinical Trials.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 186 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of citalopram for agitation in Alzheimer's dementia.
Interventions
- DRUG placebo
- DRUG citalopram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 186 participants |
| Start Date | 2009-07 |
| Est. Completion | 2013-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00898807
The ClinicalTrials.gov registry entry for NCT00898807 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 186 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is JHSPH Center for Clinical Trials, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00898807 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00898807 about?
NCT00898807 is a clinical study titled "Citalopram for Agitation in Alzheimer's Disease". The purpose of this study is to evaluate the safety and efficacy of citalopram for agitation in Alzheimer's dementia.
What is the current status of trial NCT00898807?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 186 participants. The study started on 2009-07. Estimated completion is 2013-09.
What interventions are being tested in trial NCT00898807?
The interventions under investigation include: placebo (DRUG), citalopram (DRUG).
Who is sponsoring clinical trial NCT00898807?
This trial is sponsored by JHSPH Center for Clinical Trials, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.